medigraphic.com
ISSN 0326-3428 (Print)
Órgano de difusión científica de la Asociación Nefrológica de Buenos Aires

2022, Number 3

<< Back Next >>

Rev Nefrol Dial Traspl 2022; 42 (3)

COVID-19 Disease in Kidney Transplant Recipients

Simsek A, Koca N

Language: English
References: 30
Page: 181-188
PDF size: 240.16 Kb.


ABSTRACT

Aim: Coronavirus infection can lead to severe acute respiratory distress syndrome. Information on COVİD-19 infection in patients with kidney transplants (KT) is lacking yet. In our study, clinical, radiological, laboratory features and clinical course of COVİD-19 infection in these patients were investigated. Methods: We retrospectively investigated KT recipient patients with COVID-19 diagnosed between March 15, 2020, and December 15, 2020. Clinical, radiological, laboratory features and clinical course of COVID-19 infection in these patients were recorded. Results: We identified 23 KT recipient patients with COVID-19 infection. Eighteen KT patients (78.3%) had positive reverse transcription polymerase chain reaction (RT-PCR) results for COVID-19, 5 patients (21.7%) were negative. Twelve KT patients (52.2%) were male and 11 (47.8%) were female. Fifteen of the KT patients (65.2%) had comorbidity. Thorax computed tomography showed infiltrations in 21 KT patients (91.3%). There were 14 patients (60.8%) with glomerular filtration rate (GFR) below 60 ml/ min, who were considered acute renal failure. One patient needed plasma treatment, 2 needed hemodialysis. Mortality rate was 26%. Conclusion: COVİD-19 infection causes kidney failure in patients with kidney transplant. Mortality is high in kidney transplant patients with COVİD-19 infection. Suggested poor prognostic factors increasing death risk are being 60 years or older, recent transplantation, low oxygen saturation level, high WBC count, high CRP level, high troponin level, high D-dimer level, high creatinine level, low GFR value, low sodium level.


REFERENCES

  1. Verity R, Okell LC, Dorigatti I, Winskill P, WhittakerC, Imai N, et al. Estimates of the severity of coronavirusdisease 2019: a model-based analysis. Lancet Infect Dis. 2020. pii: S1473-3099(20)30243-7.

  2. Glynn JR. Protecting workers aged 60–69 yearsfrom COVID-19. Lancet Infect Dis. 2020. pii: S1473-3099(20)30311-X.

  3. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al.Clinical Characteristics of 138 Hospitalized PatientsWith 2019 Novel Coronavirus-Infected Pneumonia inWuhan, China. JAMA. 2020. https://doi.org/10.1001/jama.2020.1585

  4. Li LQ, Huang T,Wang YQ, Wang ZP, Liang Y, HuangTB, et al. COVID-19 patients’ clinical characteristics,discharge rate, and fatality rate of metaanalysis. J MedVirol. 2020. https://doi.org/10.1002/jmv.25757

  5. Kumar D., Ferreira V.H., Blumberg E., Silveira F.,Cordero E., Perez-Romero P. A 5-Year ProspectiveMulticenter Evaluation of Influenza Infection inTransplant Recipients. Clin Infect Dis. 2018;67:1322–1329.

  6. L’Huillier A.G., Ferreira V.H., Hirzel C., NellimarlaS., Ku T., Natori Y. T-cell responses following NaturalInfluenza Infection or Vaccination in Solid OrganTransplant Recipients. Sci Rep. 2020;10:10104.

  7. Coronavirus Disease 2019 - People of Any Age withUnderlying Medical Conditions, Centers for DiseaseControl and Prevention.

  8. Cao X. COVID-19: immunopathologyand its implications for therapy. Nat RevImmunol. 2020;20:269–270.

  9. Guillen E., Pineiro G.J., Revuelta I., Rodriguez D., BodroM., Moreno A. Case report of COVID-19 in a kidneytransplant recipient: Does immunosuppression alterthe clinical presentation? Am J Transplant. 2020;20:20.

  10. Chan J.W., Ng C.K., Chan Y.H., Mok T.Y., Lee S.,Chu S.Y. Short term outcome and risk factors foradverse clinical outcomes in adults with severe acuterespiratory syndrome (SARS). Thorax. 2003;58:686–689.

  11. Park J.E., Jung S., Kim A., Park J.E. MERStransmission and risk factors: a systematic review. BMCPublic Health. 2018;18:574.

  12. Vishnevetsky A., Levy M. Rethinking highriskgroups in COVID-19. Mult Scler RelatDisord. 2020;42:102139.

  13. Mehta P., McAuley D.F., Brown M., SanchezE., Tattersall R.S., Manson J.J. COVID-19:consider cytokine storm syndromes andimmunosuppression. Lancet. 2020;395:1033-1034.

  14. Fung M., Chiu C.Y., DeVoe C., Doernberg S.B.,Schwartz B.S., Langelier C. Clinical Outcomesand Serologic Response in Solid Organ TransplantRecipients with COVID-19: A Case Series from theUnited States. Am J Transplant. 2020;01:01.

  15. 15.Yang X., Yu Y., Xu J., Shu H., Xia J., Liu H. Clinicalcourse and outcomes of critically ill patients withSARS-CoV-2 pneumonia in Wuhan, China: a singlecentered,retrospective, observational study. LancetRespir Med. 2020;8:475–481.

  16. Fernández-Ruiz M, Andrés A, Loinaz C, Delgado JF,López-Medrano F, San Juan R, et al. COVID-19 insolid organ transplant recipients: A single- center caseseries from Spain. Am J Transplant. 2020. https://doi.org/10.1111/ajt.15929

  17. Nacif, LS, Zanini LY, Waisberg DR, PinheiroRS, Galva˜OfF, Andraus W, D’Albuquerque LC.COVID-19 in solid organ transplantation patients: Asystematic review. Clinics. 2020;75:e1983

  18. Alberici F, Delbarba E, Manenti C, et al. A singlecenter observational study of the clinical characteristicsand short-term outcome of 20 kidney transplantpatients admitted for SARS-CoV2 pneumonia. KidneyInt. 2020 April 9 (Epub ahead of print).

  19. D’Antiga L. Coronaviruses and ImmunosuppressedPatients: The Facts During the Third Epidemic. LiverTransplant. 2020. https://doi.org/10.1002/lt.25756

  20. Zhou F, Yu T, Du R, et al. Clinical course andrisk factors for mortality of adult in 0patients withCOVID-19 in Wuhan, China: a retrospective cohortstudy. Lancet. 2020;395:1054-1062.

  21. Richardson S, Hirsch JS, Narasimhan M, et al.Presenting characteristics, comorbidities, and outcomesamong 5700 patients hospitalized with COVID-19 inthe New York City Area. JAMA. 2020;323:2052-2059.

  22. Cummings MJ, Baldwin MR, Abrams D, et al.Epidemiology, clinical course, and outcomes ofcritically ill adults with COVID19 in New York City: aprospective cohort study. Lancet. 2020;395:1763-1770.

  23. Cravedi P, Mothi SS, Azzi Y, Haverly M, Farouk SS,Pérez MJ. COVID-19 and kidney transplantation:Results from the TANGO International TransplantConsortium. Am J Transplant. 2020;00:1–9

  24. Hirsch JS, Ng JH, Ross DW, et al. Acute kidney injuryin patients hospitalized with COVID-19. Kidney Int.2020;98:209-218.

  25. Akalin E, Azzi Y, Bartash R, et al. Covid-19 andkidney transplantation. N Engl J Med. 2020;382:2475-2477.

  26. Pereira MR, Mohan S, Cohen DJ, et al. COVID-19in solid organ transplant recipients: initial report fromthe US epicenter. Am J Transplant. 2020;20:1800-1808.

  27. Nair V, Jandovitz N, Hirsch JS, et al. COVID-19in kidney transplant recipients. Am J Transplant.2020;20:1819-1825.

  28. Bhoori S, Rossi RE, Citterio D, Mazzaferro V.COVID-19 in long-term liver transplant patients?:preliminary experience from an Italian transplantcenter in Lombardy. Lancet Gastroenterol Hepatol.2020. pii: S2468-1253 (20)30116-3.

  29. Becchetti C, Zambelli MF, Pasulo L, Donato MF,Invernizzi F, Detry O, et al. COVID-LT group.COVID-19 in an international European livertransplant recipient cohort. Gut. 2020;69:1832–1840.

  30. Wu C, Chen X, Cai Y, et al. Risk factors associatedwith acute respiratory distress syndrome and death inpatients with coronavirus disease 2019 pneumonia inWuhan, China. JAMA Intern Med. 2020. doi:10.1001/jamainternmed.2020.0994.




2020     |     www.medigraphic.com